Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 6 | 2025 | 2087 | 1.000 |
Why?
|
| Aortic Valve Stenosis | 3 | 2024 | 378 | 0.970 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2017 | 50 | 0.880 |
Why?
|
| Mitral Valve Stenosis | 1 | 2024 | 39 | 0.860 |
Why?
|
| Patient Selection | 3 | 2025 | 730 | 0.830 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2024 | 246 | 0.800 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 185 | 0.740 |
Why?
|
| Echocardiography | 3 | 2024 | 1126 | 0.670 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 548 | 0.630 |
Why?
|
| Women's Health | 2 | 2011 | 148 | 0.620 |
Why?
|
| Registries | 2 | 2025 | 1591 | 0.600 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 297 | 0.560 |
Why?
|
| Heart Valve Prosthesis | 2 | 2014 | 331 | 0.550 |
Why?
|
| Heart Diseases | 3 | 2012 | 511 | 0.550 |
Why?
|
| Mitral Valve | 2 | 2024 | 269 | 0.540 |
Why?
|
| Menopause | 1 | 2017 | 90 | 0.530 |
Why?
|
| Blood Pressure | 3 | 2017 | 1402 | 0.440 |
Why?
|
| beta-Alanine | 1 | 2014 | 7 | 0.430 |
Why?
|
| Antithrombins | 1 | 2014 | 51 | 0.410 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 430 | 0.400 |
Why?
|
| Benzimidazoles | 1 | 2014 | 132 | 0.400 |
Why?
|
| Heart Failure | 3 | 2023 | 2398 | 0.390 |
Why?
|
| Risk Factors | 10 | 2025 | 10936 | 0.380 |
Why?
|
| Hypertension | 3 | 2024 | 1397 | 0.380 |
Why?
|
| Multidetector Computed Tomography | 1 | 2012 | 39 | 0.360 |
Why?
|
| Congresses as Topic | 3 | 2025 | 186 | 0.360 |
Why?
|
| Vascular Calcification | 1 | 2012 | 71 | 0.340 |
Why?
|
| Thrombosis | 2 | 2014 | 528 | 0.340 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 893 | 0.330 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2020 | 462 | 0.320 |
Why?
|
| Coronary Angiography | 1 | 2012 | 487 | 0.300 |
Why?
|
| Heart Neoplasms | 2 | 2016 | 105 | 0.280 |
Why?
|
| Aortic Valve | 3 | 2024 | 485 | 0.260 |
Why?
|
| Aged | 9 | 2025 | 21456 | 0.250 |
Why?
|
| Prognosis | 4 | 2024 | 5013 | 0.250 |
Why?
|
| Humans | 26 | 2025 | 132055 | 0.230 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2025 | 17 | 0.230 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2024 | 8 | 0.220 |
Why?
|
| Carotid Artery, Internal | 1 | 2024 | 58 | 0.220 |
Why?
|
| Academies and Institutes | 1 | 2025 | 88 | 0.210 |
Why?
|
| Female | 17 | 2025 | 70691 | 0.210 |
Why?
|
| Risk Assessment | 5 | 2024 | 3727 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2163 | 0.210 |
Why?
|
| Aging | 1 | 2011 | 1252 | 0.200 |
Why?
|
| Evidence-Based Medicine | 3 | 2012 | 663 | 0.200 |
Why?
|
| Middle Aged | 13 | 2025 | 28979 | 0.200 |
Why?
|
| Depression | 1 | 2012 | 1350 | 0.190 |
Why?
|
| Calcinosis | 1 | 2024 | 191 | 0.190 |
Why?
|
| Texas | 3 | 2025 | 3632 | 0.190 |
Why?
|
| Cardiac Tamponade | 1 | 2002 | 38 | 0.180 |
Why?
|
| Treatment Outcome | 7 | 2024 | 13015 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2025 | 365 | 0.170 |
Why?
|
| Stroke Volume | 1 | 2023 | 536 | 0.170 |
Why?
|
| Male | 14 | 2025 | 64944 | 0.170 |
Why?
|
| Prevalence | 3 | 2024 | 2662 | 0.170 |
Why?
|
| Cardiology | 1 | 2024 | 497 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 7125 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 2312 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2008 | 87 | 0.130 |
Why?
|
| Adult | 6 | 2025 | 31557 | 0.130 |
Why?
|
| Sex Factors | 2 | 2011 | 1352 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 106 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 3086 | 0.120 |
Why?
|
| Hospitalization | 1 | 2023 | 1897 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 270 | 0.110 |
Why?
|
| Algorithms | 1 | 2022 | 1718 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2008 | 1062 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 153 | 0.110 |
Why?
|
| Melanoma | 1 | 2002 | 954 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17367 | 0.110 |
Why?
|
| Age Factors | 2 | 2011 | 2921 | 0.110 |
Why?
|
| Dabigatran | 1 | 2014 | 29 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2022 | 1006 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1417 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 631 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1177 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 45 | 0.090 |
Why?
|
| Myocardial Ischemia | 2 | 2012 | 341 | 0.090 |
Why?
|
| Asymptomatic Diseases | 1 | 2012 | 86 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2012 | 146 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1249 | 0.090 |
Why?
|
| Comorbidity | 1 | 2016 | 1610 | 0.090 |
Why?
|
| Propensity Score | 1 | 2012 | 255 | 0.080 |
Why?
|
| Preventive Health Services | 1 | 2011 | 63 | 0.080 |
Why?
|
| Postmenopause | 1 | 2011 | 153 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 249 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 328 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 147 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2011 | 219 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2011 | 179 | 0.080 |
Why?
|
| Myocardium | 2 | 2016 | 907 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2012 | 407 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 855 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 610 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 537 | 0.070 |
Why?
|
| Body Size | 1 | 2008 | 69 | 0.070 |
Why?
|
| Protein C Deficiency | 1 | 2007 | 10 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2012 | 1078 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1160 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2007 | 206 | 0.060 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2007 | 127 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 140 | 0.060 |
Why?
|
| Hypoxia | 1 | 2007 | 259 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1307 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3852 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2008 | 1571 | 0.050 |
Why?
|
| Heart Atria | 2 | 2007 | 336 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 215 | 0.050 |
Why?
|
| Sodium | 1 | 2024 | 296 | 0.050 |
Why?
|
| Pericarditis | 1 | 2003 | 46 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9938 | 0.050 |
Why?
|
| Life Style | 1 | 2025 | 453 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2024 | 241 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 3984 | 0.040 |
Why?
|
| Pericardial Effusion | 1 | 2002 | 72 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2002 | 376 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 482 | 0.040 |
Why?
|
| Endocardium | 2 | 2012 | 54 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3129 | 0.040 |
Why?
|
| Glucose | 1 | 2024 | 871 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 553 | 0.040 |
Why?
|
| Stents | 1 | 2024 | 874 | 0.040 |
Why?
|
| Dogs | 2 | 2008 | 651 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2020 | 425 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2008 | 649 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2002 | 996 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 785 | 0.030 |
Why?
|
| United States | 1 | 2011 | 11652 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 2397 | 0.020 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 12 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 105 | 0.020 |
Why?
|
| Injections | 1 | 2012 | 152 | 0.020 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2011 | 3 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 69 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 285 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 253 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 242 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 5407 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2008 | 21 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1348 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 802 | 0.020 |
Why?
|
| Fibronectins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Laminin | 1 | 2008 | 72 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2008 | 157 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1653 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 237 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1442 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 303 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 115 | 0.020 |
Why?
|
| Thrombectomy | 1 | 2007 | 112 | 0.020 |
Why?
|
| Warfarin | 1 | 2007 | 128 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 260 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7536 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2007 | 373 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2509 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2007 | 549 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 463 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2007 | 609 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2003 | 175 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 2159 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 6556 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Animals | 2 | 2008 | 34823 | 0.010 |
Why?
|